Key Points

  • Bob Hugin brings 20 years of experience in strategic growth and global expansion at a leading biopharmaceutical anticancer company.
  • The Council is a group of goodwill ambassadors who provide strategic advice, assist with raising funds, and build awareness.


Key Points

  • HistoSonics has obtained regulatory approvals for their #HOPE4LIVER US and #HOPE4LIVER Europe clinical trials.
  • Researchers are studying histotripsy to noninvasively destroy liver tumors.
  • Patient enrollment will likely begin early this year at up to seven sites across Europe and six US sites.


Key Points

  • A recent review paper by a University of Virginia team addressed mitochondrial transfer for patients with stroke.
  • The researchers suggested focused ultrasound might improve delivery and efficacy of mitochondria to brain tissue.


Key Points

  • A pediatric patient participated in a focused ultrasound clinical trial for a disabling, painful, benign bone tumor.
  • Now, five years post-treatment, she remains free from pain.
  • In November of 2020, focused ultrasound earned FDA HDE approval to treat osteoid osteoma.

The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
434.220.4993
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903
Email
Whitelist Instructions